Serum Proinflammatory Mediators at Different Periods of Therapy in Patients With Multiple Myeloma

Multiple myeloma (MM) is a malignant disease characterized by the clonal proliferation of plasma cells within the bone marrow. Several cytokines have been demonstrated to be involved in the control of growth, progression, and dissemination of MM. We determined serum levels of interleukin-1β (IL-1β),...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuku, Irfan, Bayraktar, Mehmet Refik, Kaya, Emin, Erkurt, Mehmet Ali, Bayraktar, Nihayet, Cıkım, Kerim, Aydogdu, Ismet
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2005
Materias:
Research Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526466/
https://www.ncbi.nlm.nih.gov/pubmed/16106104
http://dx.doi.org/10.1155/MI.2005.171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526466/
https://www.ncbi.nlm.nih.gov/pubmed/16106104
http://dx.doi.org/10.1155/MI.2005.171

Ejemplares similares